Clinical Trials Browser

Phase 3 × Lung Neoplasms × Tinzaparin × Clear all

NCT03090880 2022-11-17

PROVE

Phase 3 Terminated

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT00475098 2016-09-02

TILT

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms